Do G proteins have a role in antidepressant actions?

European Neuropsychopharmacology

Volumn 6, Issue 1, 1996, Pages 49-53

  Bourin, M ^a   Baker, G B ^b  

^a UNIVERSITÉ DE NANTES   (France)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antidepressant action; G proteins

Indexed keywords

ANTIDEPRESSANT AGENT; IPRINDOLE; MIANSERIN; MONOAMINE OXIDASE INHIBITOR; PROTEIN G; PROTEIN KINASE; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VILOXAZINE;

DEPRESSION; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029987140     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-977X(95)00065-W     Document Type: Article

References (68)

1. Avissar S., Schreiber G., Danon A. and Belmaker R.H. (1988) Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331, 440-442.
2. Baker G.B. and Greenshaw A.J. (1989) Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cell. Mol. Neurobiol. 9, 1-44.
3. Banerjee S.P., Kung L.S., Rigii S.J. and Chanda S.K. (1977) Development of β-adrenergic receptor subsensitivity by antidepressants. Nature 268, 455-456.
4. Berendsen H.H.G. (1995) Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans? Pharmacol. Ther. 66, 17-37.
5. Blier P. and de Montigny C. (1994) Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15, 220.
6. Brunello N., Riva M., Voltera A. and Racagni G. (1986) Biochemical changes in rat brain after acute and chronic administration of fluvoxamine, a selective 5-HT uptake blocker: comparison with desmethylimipramine. Adv. Pharmacother. 2, 186-196.
7. Brunello N., Perez J., Tinelli D., Rovescalli A.C. and Racagni G. (1990) Biochemical and molecular changes in rat cerebral cortex after chronic antidepressant treatment. Pharmacol. Toxicol. 66, 112-120.
8. Bulter M.O., Morinbu S. and Duman R.S. (1993) Chronic electroconvulsive seizures increase the expression of serotonin 2 receptor mRNA in rat frontal cortex. J. Neurochem. 61, 1-7.
9. Byerley W.F., McConnell E.J., McCabe R.T., Dawson T.M., Grosser B.I. and Wamsley J.K. (1987) Chronic administration of sertraline, a selective serotonin uptake inhibitor, decreased the density of β-adrenergic receptors in rat frontoparietal cortex. Brain Res. 421, 377-381.
10. Byerley W.F., McConnell E.J., McCabe R.T., Dawson T.M., Grosser B.I. and Wamsley J.K. (1988) Decreased β-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetine. Psychopharmacology 94, 141-143.
11. Cadogan A.K., Marsden C.A., Tulloch I. and Kendall D.A. (1993) Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig. Neuropharmacology 32, 249-256.
12. Cassano G.B. and Marazziti D. (1992) Is depression a disorder of a receptor superfamily? A critical review of the receptor theory of depression and the appraisal of an new heuristic model. Eur. Psychiatry 7, 259-270.
13. Colin S.F., Chang H.-C., Mollner S. et al. (1991) Chronic lithium regulates the expression of adenylate cyclase and Giα in rat cerebral cortex. Proc. Natl. Acad. Sci. USA 88, 10634-10637.
14. Deakin J.F.W., Guimaraes F.S., Wang M. and Hensman R. (1991) Experimental tests of the 5-HT receptor imbalance theory of affective disturbance. In: M. Sandler, A. Coppen and S. Harnett (Eds.), 5-Hydroxytryptamine in Psychiatry - A Spectrum of Ideas. Oxford University Press, Oxford, pp. 143-156.
15. Duman R.S. and Nestler E.J. (1995) Signal transduction pathways for catecholamine receptors. In: F.E. Bloom and D.J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, pp. 303-320.
16. Duman R.S., Terwilliger R.Z. and Nestler E.G. (1989) Chronic antide-pressant regulation of Gsα and cyclic AMP dependant protein kinase. Pharmacologist 31, 182.
17. Eison A., Yocca F.D. and Gianutsos G. (1991) Effect of chronic administration of antidepressant drugs on 5-HT2 mediated behavior in the rat following noradrenergic or serotoninergic denervation. J. Neural Transm. 84, 19-32.
18. Garcha G., Smokum R.W.J., Stephenson J.D. and Weeamanthri T.B. (1985) Effects of some atypical antidepressants on β-adrenoceptor binding and adenylate cyclase activity in the rat forebrain. Eur. J. Pharmacol. 108, 1-7.
19. Gilman A.G. (1987) G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56, 615-649.
20. Goodnough D.B. and Baker G.B. (1994) 5-Hydroxytryptamine 2 and β-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J. Neurochem. 62, 2262-2268.
21. Green A.R., Johnson P. and Nimgaonkar V.L. (1983) Inreased 5-HT receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats. Br. J. Pharmacol. 80, 173-177.
22. Heninger G.R. and Charney D.S. (1987) Mechanisms of action of antidepressant treatments: implications for the etiology and treatment of depressive disorders. In: H.Y. Meltzer (Ed.), Psychopharmacology: The Third Generation of Progress, Raven Press, New York, pp. 535-544.
23. Hrdina P.D. (1993) Is there action beyond receptors? J. Psychiat. Neurosci. 18, 57-59.
24. Hrdina P.D. and Vu T.B. (1993) Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study. Synapse 14, 324-331.
25. Hsia J.K., Manji H.K., Chen G.A., Bitran J.A., Risby E.D. and Potter W.Z. (1992) Lithium administration modulated platelet Gi in humans. Life Sci. 50, 227-233.
26. Hudson C.J., Young L.T., Li P.P. and Warsh J.J. (1993) CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 13, 278-293.
27. Hyttel J. (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int. Clin. Psychopharmacol. 9 (Suppl. 1), 19-26.
28. Johnson A.M. (1991) The comparative pharmacological properties of selective serotonin reuptake inhibitors in animals. In: J.P. Feighner and W.F. Boyer (Eds.). Perspectives in Psychiatry, Vol. 1, Selective Serotonin Reuptake Inhibitors, Wiley, Chichester, pp. 37-70.
29. Kellar K.J., Cascio C.S., Butler J.A. and Kurtzke R.N. (1981) Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur. J. Pharmacol. 69, 515-518.
30. Koe B.K., Koch S.W., Lebel L.A., Minor K.W. and Page M.G. (1987) Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of β-adrenoceptor system of rat brain. Eur. J. Pharmacol. 141, 187-194.
31. Lesch K.P. and Manji H.K. (1992) Signal-transducing G proteins and antidepressant drugs - evidence for modulation of α-subunit gene expression in rat brain. Biol. Psychiatry 32, 549-579.
32. Lesch K.P., Aulakh C.S., Tolliver T.J., Hill J.L. and Murphy D.L. (1991) Regulation of G proteins by chronic antidepressant drugs in rat brain: tricyclics but not clorgyline increase Goa subunits. Eur. J. Pharmacol. Mol. Sect. 207, 361-364.
33. Lesch K.P., Hough C.J., Aulakh C.S., Wolozin B.L., Tolliver T.J., Hill J.L., Akiyoshi J., Chuang D.M. and Murphy D.L. (1992) Fluoxetine modulates G protein αs, αq and α-12 subunit messenger RNA expression in rat brain. Eur. J. Pharmacol. Mol. Pharm. 327, 233-237.
34. Li P.P., Tam Y-K., Young T. and Warsh J.J. (1991) Lithium decreases Gs, Gi-1 and Gi-2 α-subunit mRNA levels in rat cortex. Eur. J. Pharmacol. 206, 165-166.
35. Li P.P., Emanghoreishi M., Sibony D. and Warsh JJ. (1993) Chronic antidepressant treatment does not alter the levels of Gs and Gi α-subunit transcript and immunoreactivity in rat cortex. Soc. Neurosci. Abstr. 19, 1868.
36. Linder M.E. and Gilman A.G. (1992) G proteins. Sci. Am. 267, 55-65.
37. Manji H.K. (1992) G proteins: implications for psychiatry. Am. J. Psychiatry 52, 746-760.
38. Manji H.K., Potter W.A. and Lenox R.H. (1995) Signal transduction pathways. Arch. Gen. Psychiatry 52, 531-543.
39. Mann C.D., Vu T.B. and Hrdina P.D. (1995) Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine. Br. J. Pharmacol. 115, 595-600.
40. Maus M., Homburger V., Bockaert J., Glowinski J. and Premont J. (1990) Pretreatment of mouse striatal neurons in primary culture with 17β-estradiol enhances the pertussis toxin-catalyzed ADP-ribosylation of Gαo,i protein subunits. J. Neurochem. 55, 1244-1251.
41. Milligan G. (1993) Mechanisms of multifunctional signalling by G protein-linked receptors. Trends Pharmacol. Sci. 14, 239-244.
42. Nalepa I. and Vetulani J. (1993) Enhancement of the responsiveness of cortical adrenergic receptors by chronic administration of the 5-hydroxytryptamine uptake inhibitor citalopram. J. Neurochem. 60, 2029-2035.
43. Nelson D.R., Pratt G.D., Palmer K.J., Johnson A.M. and Bowery N.G. (1991) Effect of paroxetine, a selective 5-hydroxytryptamine uptake inhibitor, on β-adrenoceptors in rat brain: autoradiographic and functional studies. Neuropharmacology 30, 607-616.
44. Nestler E.J., Terwilliger R.Z. and Duman R.S. (1989) Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J. Neurochem. 53, 1644-1647.
45. 1A receptor-mediated effects of antidepressants. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 17, 1-8.
46. Ozawa H. and Rasenick M.M. (1989) Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment. Mol. Pharmacol. 36, 803-806.
47. Ozawa H. and Rasenick M.M. (1991) Chronic electroconvulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J. Neurochem. 56, 330-338.
48. Pälvimäki E.-P., Laakso A., Kuoppamäki M., Syvälahti E. and Hietala J. (1994) Up-regulation of β1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments. Psychopharmacology 115, 543-546.
49. Papp M., Klimek V. and Willner P. (1994) Effects of imipramine on serotonergic and β-adrenergic receptor binding in a realistic animal model of depression. Psychopharmacology 114, 309-314.
50. Perez J., Tinelli D., Bianchi E., Brunello N. and Racagni G. (1994) Cyclic AMP binding proteins in the rat cortical cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity. Neuropsychopharmacology 41, 57-64.
51. Peroutka S.J. and Snyder S.H. (1980) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210, 88-90.
52. Pfeiffer A., Veilleux S. and Barden N. (1991) Antidepressant and other centrally acting drugs regulate glucorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology 16, 505-515.
53. Saito N., Guitar X., Hayward M., Tallman J.F., Duman R.S. and Nestler E. (1989) Corticosterone differentially regulates the expression of Gsα and Giα messenger RNA and protein in rat cerebral cortex. Proc. Natl. Acad. Sci. USA 86, 3906-3910.
54. Sanders-Bush E., Breeding M., Knoth K. and Tsutsumi M. (1989) Sertraline-induced desensitization of the serotonin 5-HT2 receptor transmembrane signaling system. Psychopharmacology 99, 64-69.
55. Schreiber G., Avissar S., Danon A. and Belmaker R.H. (1991) Hyperfunctional G proteins in mononuclear leukocytes of patients with mania. Biol. Psychiatry 29, 273-280.
56. Stahl S. (1994) Is serotonin receptor down-regulation linked to the mechanisms of action of antidepressant drugs? Psychopharmacol. Bull. 30, 39-43.
57. Sugrue M.F. (1983) Do antidepressants possess a common mechanism of action? Biochem. Pharmacol. 32, 1811-1817.
58. Sulser F. (1993) The aminergic 'link hypothesis' of affective disorders: a molecular view of therapy-resistant depression. In: Proc. 3rd Ann. Bristol-Myers Squibb Symp. on Neurosci. Res., Neurobiology of Affective Disorders, Raven Press, New York, 7-12.
59. Sulser F., Janowsky A.J., Okada F., Manier D.H. and Mobley P.L. (1983) Regulation of recognition and action function of the norepinephrine (NE) receptor-coupled adenylate cyclase system in brain: Implications for the therapy of depression. Neuropharmacology 22, 425-431.
60. Todd K.G., McManus D.J. and Baker G.B. (1995) Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine 2A receptors without affecting benzodiazepine binding sites in rat brain. Cell. Mol. Neurobiol. 15, 361-370.
61. Vetulani J. and Sulser F. (1975) Action of various antidepressant treatment reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forbrain. Nature 257, 495-496.
62. Vetulani J., Lebrecht U. and Pilc A. (1981) Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment. Eur. J. Pharmacol. 76, 81-85.
63. Wachtel H. (1989) Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesizing defects beyond first messenger receptors. J. Neural Transm. 75, 21-29.
64. Wilcox R.E. and Gonzales R.A. (1995) Introduction to neurotransmitters, receptors, signal transduction, and second messengers. In: A.F. Schatzberg and C.B. Nemeroff (Eds.), The American Psychiatric Press Textbook of Psychopharmacology, American Psychiatric Press, Washington, DC, pp. 3-29.
65. Wong D.T., Bymaster F.P. and Engleman E.A. (1995) Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 57, 411-441.
66. Young L.T., Li P.P., Kish S.J., Siu K.P. and Warsh J.J. (1991) Post mortem cerebral cortex Gsα subunit levels are elevated in bipolar affective disorder. Brain Res. 553, 323-326.
67. Young L.T., Li P.P., Kish S.J., Siu K.P. and Warsh J.J. (1993) Cerebral cortex Gsa protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J. Neurochem. 61, 890-898.
68. Young L.T., Li P.P., Kamble A., Siu K.P. and Warsh J.J. (1994) Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder. Am. J. Psychiatry 151, 594-596.